Next generation sequencing NGS News and Research

RSS

New test may improve the ability to diagnose riskiest forms of HPV infection

Ninety-nine percent of cervical cancers are caused by human papillomavirus (HPV). More than 200 HPVs, some of which are associated with varying degrees of cancer risk, complicate diagnosis and treatment.

12 Aug 2019

Fraunhofer scientists develop method for measuring a person’s biological age

Chemical reactions and molecular modifications change the genome of each and every human over the course of their lifetime.

3 Aug 2019

IDT chosen as primary supplier of NGS oligo products for Clear Labs’ NGS-based food safety platform

As part of its ongoing mission to break down the barriers in genomics research, Integrated DNA Technologies is extending its network of collaborations into food quality and safety.

From Integrated DNA Technologies 26 Jul 2019

Abbott launches STARLIMS Life Sciences Solution 11.1 to help manage complex workflows

Abbott announced the launch of a laboratory information management system, STARLIMS Life Sciences Solution 11.1, to help manage complex sample and testing workflows, as well as help drive data safety and integrity throughout the entire lifecycle.

From Abbott Laboratories Inc. 19 Jul 2019

IDT partners with Washington University to increase access to new NGS technologies

As part of its commitment to advocate for the genomics age, Integrated DNA Technologies aims to lower the barriers to access the latest NGS technologies.

From Integrated DNA Technologies 19 Jul 2019

New telementoring program seeks to improve quality of care for breast cancer patients

A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers' knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.

2 Jul 2019

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019

IDT enters into strategic collaboration with Chinese medical sequencing firm ChosenMed

Integrated DNA Technologies announces that it has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China.

From Integrated DNA Technologies 28 Jun 2019

Disrupting ChIP Assay Technology with New Advancements

The Chromatrap ChIP technology is a bead-free method of performing ChIP. The potential of the technology emerged from our capabilities in manufacturing porous plastic filters for the filtration and separation of biological materials.

From Chromatrap® - Porvair Sciences Ltd 27 Jun 2019

Role of biochip advancements in next-generation sequencing

Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.

26 Jun 2019

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

In this interview, Prof. Elborn and Dr. Dixon discuss the issues involving chronic lung conditions such as cystic fibrosis and bacterial respiratory infections.

From Neem Biotech 25 Jun 2019

MSK receives approval for new molecular assay from New York State Department of Health

Memorial Sloan Kettering Cancer Center announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status.

24 Jun 2019

IDT unveils latest additions to NGS portfolio at European Human Genetics Conference

As part of its ongoing mission to advocate for researchers in the genomics age, Integrated DNA Technologies will unveil the latest additions to its NGS catalog to the European market at the European Human Genetics Conference in Gothenburg, Sweden on 15–18 June, 2019.

From Integrated DNA Technologies 13 Jun 2019

OGT expands SureSeq NGS portfolio with a complete library preparation solution

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq portfolio with a complete library preparation solution for hybridization-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.

From Oxford Gene Technology 13 Jun 2019

Heart failure drug could be effective in treating leukemia

Canadian researchers followed their intuition that a drug initially intended for heart failure could be effective in treating cancer. Those efforts have borne fruit, as demonstrated by their work published in the Journal of Experimental and Clinical Cancer Research.

13 Jun 2019

Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay

Roche Diagnostics today announced the launch of the VENTANA ROS1 Antibody, the first and only in vitro diagnostic ROS1 immunohistochemistry assay. The test detects the presence of ROS1 protein in tissue, and may be useful in identifying ROS1-positive lung cancer cases.

From Roche Sequencing and Life Science 10 Jun 2019

Researchers mobilize globally to improve smoking cessation tools as World No Tobacco Day approaches

More than 30 years after World No Tobacco Day was launched to raise awareness of the devastating health effects of tobacco use, there are still more than a billion smokers in the world.

31 May 2019

Researchers discover healthy, stress-busting fat in soil-dwelling bacteria

Thirty years after scientists coined the term "hygiene hypothesis" to suggest that increased exposure to microorganisms could benefit health, University of Colorado Boulder researchers have identified an anti-inflammatory fat in a soil-dwelling bacterium that may be responsible.

29 May 2019

Epigenetic research provides new approaches to cancer combination therapies

Epigenetic processes enable cells to respond to changes in their environment by regulating the activity of their genes.

28 May 2019

Longas offers Morphoseq technology for highly accurate long read sequencing on short read NGS platforms

Longas Technologies Pty Ltd, a developer of Next Generation Sequencing technologies, has provided details on its Morphoseq library prep and associated software technology at the ‘Sequencing, Finishing and Analysis in the Future’ meeting, May 21 – 23, Santa Fe, NM, USA, that enables long read sequencing on short read NGS platforms.

23 May 2019